Atrovent HFA Related Published Studies
Well-designed clinical trials related to Atrovent HFA (Ipratropium Cation Inhalation)
Ipratropium bromide HFA. [2005]
Well-designed clinical trials possibly related to Atrovent HFA (Ipratropium Cation Inhalation)
Repeated dyspnea score and percent FEV1 are modest predictors of
hospitalization/relapse in patients with acute asthma exacerbation. [2014]
Priming of beta-2 agonist and antimuscarinic induced physiological responses
induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study. [2014]
Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique. [2008]
Respimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction. [2005]
Other research related to Atrovent HFA (Ipratropium Cation Inhalation)
COPD patient satisfaction with ipratropium bromide/albuterol delivered via
Respimat: a randomized, controlled study. [2013]
Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption. [2010.02.01]
Other possibly related research studies
Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers. [2005.09]
N-nitrosamines as "special case" leachables in a metered dose inhaler drug product. [2009.07]
Effects of nebulized budesonide as an adjunct to standard treatment of asthma
exacerbations: a randomized, double-blind, placebo-controlled trial. [2014]
Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic
medications. [2014]
A comparative study of two nebulizers in the emergency department:
breath-actuated nebulizer and handheld nebulizer. [2014]
|
